BTBD10 functions as an activator of AKT family members by inhibiting PPP2CA-mediated dephosphorylation, and a few studies have identified it as a prognostic risk factor in hepatocellular carcinoma (36) and glioma (37). This evidence concerns the gene AKT1 and hepatocellular carcinoma.